TRAJKOVA, S.; STAVRIDIS, I. P.; STOJANOVIC, A.; PETRUSEVSKA, G.; DUKOVSKI, D.; IVANOVSKI, M.; VELJANOVSKA, A. P.; SIMJANOVSKA, M. P.; CADIEVSKI, L.; CEVRESKA, L. Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience. International Journal of Research in Medical Sciences, [S. l.], v. 1, n. 2, p. 47–52, 2017. Disponível em: https://www.msjonline.org/index.php/ijrms/article/view/2556. Acesso em: 16 apr. 2026.